Vaccines for preventing rotavirus diarrhoea: vaccines in use

K Soares‐Weiser, H Bergman… - Cochrane database …, 2019 - cochranelibrary.com
Background Rotavirus results in more diarrhoea‐related deaths in children under five years
than any other single agent in countries with high childhood mortality. It is also a common …

Understanding rotavirus vaccine efficacy and effectiveness in countries with high child mortality

T Varghese, G Kang, AD Steele - Vaccines, 2022 - mdpi.com
Rotavirus claims thousands of lives of children globally every year with a disproportionately
high burden in low-and lower-middle income countries where access to health care is …

Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials

A Clark, K van Zandvoort, S Flasche… - The Lancet Infectious …, 2019 - thelancet.com
Background The duration of protection offered by rotavirus vaccines varies across the world,
and this variation is important to understanding and predicting the effects of the vaccines …

A systematic review of the effect of rotavirus vaccination on diarrhea outcomes among children younger than 5 years

LM Lamberti, S Ashraf, CLF Walker… - The Pediatric infectious …, 2016 - journals.lww.com
Background: Rotavirus is the leading cause of vaccine-preventable diarrhea among children
under 5 globally. Rotavirus vaccination has been shown to prevent severe rotavirus …

Healthcare as a driver, reservoir and amplifier of antimicrobial resistance: opportunities for interventions

D Cocker, G Birgand, N Zhu… - Nature Reviews …, 2024 - nature.com
Antimicrobial resistance (AMR) is a global health challenge that threatens humans, animals
and the environment. Evidence is emerging for a role of healthcare infrastructure …

Use of vaccines as probes to define disease burden

DR Feikin, JAG Scott, BD Gessner - The Lancet, 2014 - thelancet.com
Vaccine probe studies have emerged in the past 15 years as a useful way to characterise
disease. By contrast, traditional studies of vaccines focus on defining the vaccine …

[HTML][HTML] The efficacy and safety of rotavirus vaccines in countries in Africa and Asia with high child mortality

N Henschke, H Bergman, D Hungerford, NA Cunliffe… - Vaccine, 2022 - Elsevier
Rotavirus remains a leading cause of diarrhoeal morbidity and mortality in young children
and rotavirus vaccines are critical for reducing global disease burden. This report addresses …

Vaccines for preventing rotavirus diarrhoea: vaccines in use

H Bergman, N Henschke, D Hungerford… - Cochrane Database …, 2021 - cochranelibrary.com
Background Rotavirus is a common cause of diarrhoea, diarrhoea‐related hospital
admissions, and diarrhoea‐related deaths worldwide. Rotavirus vaccines prequalified by …

The public health value of vaccines beyond efficacy: methods, measures and outcomes

A Wilder-Smith, I Longini, PL Zuber, T Bärnighausen… - BMC medicine, 2017 - Springer
Background Assessments of vaccine efficacy and safety capture only the minimum
information needed for regulatory approval, rather than the full public health value of …

[HTML][HTML] Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life

N Bhandari, T Rongsen-Chandola, A Bavdekar, J John… - Vaccine, 2014 - Elsevier
Rotavirus gastroenteritis is one of the leading causes of diarrhea in Indian children less than
2 years of age. The 116E rotavirus strain was developed as part of the Indo-US Vaccine …